Opportunity Information: Apply for PAR 21 067

The Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed), funding opportunity number PAR-21-067, is a discretionary grant program run by the National Institutes of Health (NIH), specifically aligned with the National Cancer Institute (NCI). It sits under the NIH Research Education Program (R25), which is designed to support structured educational activities that strengthen and expand the nations biomedical, behavioral, and clinical research workforce. In practical terms, this opportunity is meant to fund well-designed education programs that help people build cancer research skills and move into, or advance within, research-related careers. The emphasis in this particular announcement is on research experiences, meaning hands-on, mentored, and thoughtfully organized opportunities that immerse participants in cancer-focused research environments rather than purely classroom-based instruction.

The core purpose is workforce development in areas tied directly to cancer, including the causes of cancer, methods for diagnosis, prevention strategies, treatment approaches, rehabilitation after cancer, and the ongoing care of cancer patients as well as support for their families. Competitive applications are expected to be innovative and state-of-the-art, which usually translates into programs that reflect current scientific methods and emerging technologies, incorporate modern research practices, and provide participants with meaningful, supervised research engagement. The overall intent is not simply to provide information, but to create training and educational experiences that complement existing training pipelines and address gaps in the preparation of future researchers and research-informed professionals.

A key restriction is captured in the title: clinical trials are not allowed under this FOA. That generally means applicants need to design education and research experience activities that do not propose conducting NIH-defined clinical trials as part of the grant-supported work. Programs can still focus on clinical and translational cancer topics in an educational sense, and they can provide research experiences in many settings, but the funded activities cannot include running a clinical trial within the scope of the award.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments that are federally recognized; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (when not an institution of higher education); for-profit organizations other than small businesses; small businesses; and other entities that meet NIH eligibility rules. The announcement also explicitly calls out additional eligible applicant categories often associated with broadening participation and community engagement, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

On the foreign eligibility side, the rules are specific. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply. However, foreign components, as NIH defines them in the NIH Grants Policy Statement, are allowed. In other words, the applicant organization must be domestic and eligible, but certain well-justified foreign collaborations or components can be included if they fit NIH policy and are proposed appropriately.

In terms of administrative details provided in the source data, the program is categorized under Education and Health, with CFDA number 93.398. The funding instrument type is a grant. The opportunity record shows an original closing date of 2021-08-26 and a creation date of 2020-11-17. The award ceiling and expected number of awards are not specified in the provided excerpt, which typically means applicants would need to consult the full FOA text and any associated NIH budget guidance to understand anticipated funding levels, project period limits, and allowable costs for the education and research experience activities they propose.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.398.
  • This funding opportunity was created on 2020-11-17.
  • Applicants must submit their applications by 2021-08-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 067

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

1) What is the name of this grant opportunity?

This opportunity is the Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed).

2) What is the funding opportunity number?

The funding opportunity number (FOA) is PAR-21-067.

3) Which federal agency runs this program?

The program is run by the National Institutes of Health (NIH) and is specifically aligned with the National Cancer Institute (NCI).

4) What type of NIH program is this?

It sits under the NIH Research Education Program (R25), which supports structured educational activities intended to strengthen and expand the nation’s biomedical, behavioral, and clinical research workforce.

5) What is the main purpose of this opportunity?

The main purpose is workforce development for cancer-related research fields by funding well-designed education programs that build cancer research skills and help participants move into, or advance within, research-related careers.

6) What does "Research Experiences" mean in this context?

In this announcement, "research experiences" emphasizes hands-on, mentored, thoughtfully organized opportunities that immerse participants in cancer-focused research environments, rather than being purely classroom-based instruction.

7) What cancer-related areas does the program aim to support?

The opportunity targets workforce development in areas tied directly to cancer, including: causes of cancer, diagnosis methods, prevention strategies, treatment approaches, rehabilitation after cancer, ongoing care of cancer patients, and support for patients’ families.

8) What kinds of program characteristics are expected to be competitive?

Competitive applications are expected to be innovative and state-of-the-art. Based on the description, that generally means programs reflecting current scientific methods and emerging technologies, incorporating modern research practices, and providing meaningful, supervised research engagement.

9) Is this grant intended to replace existing training programs?

No. The stated intent is for the educational and training experiences to complement existing training pipelines and address gaps in the preparation of future researchers and research-informed professionals.

10) Are clinical trials allowed under this FOA?

No. A key restriction is that clinical trials are not allowed under this funding opportunity.

11) What does "Clinical Trial Not Allowed" mean for proposed activities?

It means applicants should not propose conducting NIH-defined clinical trials as part of the grant-supported work. The program may still focus on clinical and translational cancer topics in an educational sense, and may offer many kinds of research experiences, but it cannot include running a clinical trial within the scope of the award.

12) Who is eligible to apply (in general terms)?

Eligibility is broad for U.S.-based organizations and governmental entities that meet NIH eligibility rules, including many kinds of government bodies, educational institutions, nonprofits, for-profits, and small businesses.

13) What types of government entities are listed as eligible applicants?

Eligible government entities listed include state governments, county governments, city or township governments, special district governments, and independent school districts.

14) Are colleges and universities eligible?

Yes. Eligible applicants include public and state-controlled institutions of higher education and private institutions of higher education.

15) Are nonprofits eligible to apply?

Yes. Nonprofits with or without 501(c)(3) status are listed as eligible when they are not an institution of higher education.

16) Are for-profit organizations eligible?

Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.

17) Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are listed as eligible, and tribal organizations that are not federally recognized are also listed as eligible.

18) Are public housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are included in the eligibility list.

19) Are minority-serving institutions or institutions focused on broadening participation specifically mentioned?

Yes. The announcement explicitly calls out categories including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

20) Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly mentioned among eligible applicant categories.

21) Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are explicitly listed as eligible.

22) Are non-U.S. (foreign) organizations eligible to apply as the main applicant?

No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.

23) Can a U.S. organization apply if part of the project would occur at a non-domestic component of that U.S. organization?

No. Non-domestic components of U.S. organizations are also not eligible to apply.

24) Are any foreign activities allowed at all?

Yes, with an important distinction: foreign components (as NIH defines them in the NIH Grants Policy Statement) are allowed. This means the applicant must be a domestic eligible organization, but certain well-justified foreign collaborations or components can be included if proposed appropriately under NIH policy.

25) What category is this program listed under?

The program is categorized under Education and Health in the provided information.

26) What is the CFDA number for this opportunity?

The CFDA number listed is 93.398.

27) What is the funding instrument type?

The funding instrument type is a grant.

28) What was the original closing date shown in the record?

The opportunity record shows an original closing date of 2021-08-26.

29) What is the opportunity creation date shown in the record?

The record shows a creation date of 2020-11-17.

30) Is the award ceiling listed in the provided information?

No. The award ceiling is not specified in the provided excerpt.

31) Is the expected number of awards listed in the provided information?

No. The expected number of awards is not specified in the provided excerpt.

32) Where should applicants look for details like budget guidance, project period limits, and allowable costs?

Because the award ceiling and expected number of awards are not included in the excerpt, applicants would typically need to consult the full FOA text and any associated NIH budget guidance to understand anticipated funding levels, project period limits, and allowable costs for proposed education and research experience activities.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Department of the Interior – Bureau of Land Management New Mexico/Oklahoma/Kansas/Texas (NM) Plant Conservation and Restoration Management

Previous opportunity: Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 067

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 067) also looked into and applied for these:

Funding Opportunity
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 003

Funding Number: RFA CA 21 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 005

Funding Number: RFA CA 21 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 004

Funding Number: RFA CA 21 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 006

Funding Number: RFA CA 21 006
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) Apply for RFA CA 21 009

Funding Number: RFA CA 21 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 21 008

Funding Number: RFA CA 21 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 21 012

Funding Number: RFA CA 21 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 21 007

Funding Number: RFA CA 21 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 21 011

Funding Number: RFA CA 21 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 21 010

Funding Number: RFA CA 21 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 21 001

Funding Number: RFA CA 21 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 21 014

Funding Number: RFA CA 21 014
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) Apply for RFA CA 21 002

Funding Number: RFA CA 21 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,250,000
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 21 031

Funding Number: RFA DA 21 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 21 032

Funding Number: RFA DA 21 032
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) Apply for PAR 21 099

Funding Number: PAR 21 099
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional) Apply for RFA DA 21 015

Funding Number: RFA DA 21 015
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $256,580
Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional) Apply for RFA DA 21 016

Funding Number: RFA DA 21 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $256,580
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) Apply for PAR 21 100

Funding Number: PAR 21 100
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed) Apply for RFA DA 21 041

Funding Number: RFA DA 21 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 067", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: